Client News
TVM Capital Life Science Announces creation of LAmAb Biologics to develop innovative preventative therapy for allergy patients
Spexis and SPRIM Global Investments (SGI) announce plans for clinical trial partnership to fund up to half of the projected Phase 3 clinical development costs of ColiFin®
Carbios appoints four new Board members to strengthen international expertise in brand development, business growth and scientific research
TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.
Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer
Andera Partners participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches
Carbios strengthens Executive Committee in pivotal year for industrial and commercial development
Destiny Pharma: US Center for Disease Control (CDC) and two major medical journals cite the importance of decolonization in preventing surgical site infections
ONWARD strengthens leadership team with key appointments in clinical & regulatory and marketing
